Mutations in the epidermal growth factor receptor (EGFR) gene are commonly observed in
non-small-cell lung cancer (NSCLC), particularly in tumors of adenocarcinoma (ADC) …

Lung cancer is the leading cause of cancer-related mortality. While the majority of lung
cancers are associated with tobacco smoke, approximately 10–15% of US lung cancers …

Lung cancer is one of the most incident types of cancer and a leading cause of cancer
mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data …

Cancer is now known as a disease of genomic alterations. Mutational analysis and
genomics profiling in recent years have advanced the field of lung cancer …

Lung cancer is the most common cancer worldwide. Up to 85% of lung cancer cases are
diagnosed as non-small cell lung cancer (NSCLC). The effectiveness of NSCLC treatment is …

Latinos have lower rates for most common cancer sites and higher rates of some less
common cancers (gallbladder, liver, gastric, and cervical) than other ethnic/racial groups …

RESUMO O câncer de pulmão é um dos tipos de câncer com maior incidência e uma das
principais causas de mortalidade por câncer no Brasil. Revisamos a situação atual do …

Introduction Mutations in EGFR and KRAS can impact treatment decisions for patients with
NSCLC. The incidence of these mutations varies, and it is unclear whether there is a …

Background: KRAS and BRAF targets are involved in the epidermal growth factor receptor
pathway. KRAS and BRAF targets are the most frequent driver mutations in cancer …

Lung cancer is the deadliest cancer worldwide. The mutational frequency of EGFR and
KRAS genes in lung adenocarcinoma varies worldwide per ethnicity and smoking. The …